CompletedNot Applicable

Sleep Extension for Metabolic Health

United Kingdom18 participantsStarted 2017-04-15

Plain-language summary

The study aims to examine the effects of a sleep extension intervention on the metabolic and cardio-vascular profile of obese people who present traditional diabetes risk factors, and who are habitually sleep deprived. Participants randomized to the intervention arm will complete a 6-week sleep extension intervention, whilst the control group will maintain their habitual sleep schedule. It is hypothesized that the sleep extension intervention will significantly increase total sleep time, and will be accompanied by significant metabolic-related changes.

Who can participate

Age range25 Years – 55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 25 to 55 years (inclusive) * Gender: Men * BMI \> 25kg/m2 * Average self-reported sleep duration of ≤ 6h per 24h * Stable daily sleep/wake schedule * Health risk screening score ≥ 2 Exclusion Criteria: * Diagnosed sleep disorder as per DSM-5: e.g. insomnia, restless legs syndrome, moderate/severe Obstructive Sleep Apnoea; Epworth Sleepiness Score: \<5 * Diagnosed chronic conditions, or medication, likely to interfere with regular sleep: T2D, chronic fatigue syndrome, fibromyalgia, COPD, uncontrolled depression/anxiety, other severe psychiatric illness, substance abuse. * Night/evening shift work , regular time-zone travel, other circumstances preventing regular sleep schedule (e.g. very young children, carer at night for sick relatives etc)

What they're measuring

Total sleep time (TST)

Timeframe: 24 hours

Trial details

NCT IDNCT04467268

SponsorLoughborough University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04-15

View on ClinicalTrials.gov More Short Sleep trials